Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Canadian Journal of Cardiology
- Prevalence and treatment patterns of lower extremity peripheral arterial disease among patients at risk in ambulatory health settings.Can J Cardiol. 2011; 27 (e11-8): 389
- Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.Lancet Glob Health. 2019; 7: e1020-e1030
- Complex evolution of epidemiology of vascular diseases, including increased disease burden: from 2000 to 2015.Can J Cardiol. 2020; 36: 740-746
- Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease.Arterioscler Thromb Vasc Biol. 2020; 40: 1808-1817
- Recent temporal changes in atherosclerotic cardiovascular diseases in Ontario: clinical and health systems impact.Can J Cardiol. 2017; 33: 378-384
- International Statistical Classification of Diseases and Related Health Problems. Tenth Revision, Canada. Canadian Institute for Health Information, 2015
ICD 10 Version: 2016. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Available at: https://icd.who.int/browse10/2016/en. Accessed November 23, 2020.
SAS. SAS/ETSreg; 13.2 User's Guide. The AUTOREG Procedure. Available at: https://support.sas.com/documentation/onlinedoc/ets/132/autoreg.pdf. Accessed May 14, 2021.
- A new look at the statistical model identification.IEEE Trans Automat Contr. 1974; 19: 716-723
- Recent trends in hospitalizations for cardiovascular disease, stroke, and vascular cognitive impairment in Canada.Can J Cardiol. 2020; 36: 1081-1090
- Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.BMJ Open. 2018; 8e018184
- Peripheral angioplasty with same-day discharge in patients with intermittent claudication.J Vasc Surg. 2006; 44: 115-118
- Evolving trends in the epidemiology, risk factors, and prevention of type 2 diabetes: a review.Can J Cardiol. 2018; 34: 552-564
- Type 2 diabetes in adolescents and young adults.Lancet Diabetes Endocrinol. 2018; 6: 69-80
- Peripheral arterial disease in people with diabetes.Diabetes Care. 2003; 26: 3333-3341
- Global vascular guidelines on the management of chronic limb-threatening ischemia.J Vasc Surg. 2019; 69 (e40): 3S-125S
- Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease.CMAJ. 2019; 191: E955-E961
- Trends in incidence of total or type 2 diabetes: systematic review.BMJ. 2019; 366: l5003
- Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis.JAMA. 2020; 9e014742
- Statin adherence: does gender matter?.Curr Atheroscler Rep. 2016; 18: 63
- Adherence to medication according to sex and age in the CHARM programme.Eur J Heart Fail. 2009; 11: 1092-1098
- Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus.Diabetes Res Clin Pract. 2012; 97: 377-384
- Validation of diagnosis and procedure codes for revascularization for peripheral artery disease in Ontario administrative databases.Clin Invest Med. 2021; 44: E36-E43
See editorial by Hackam, pages 1496–1497 of this issue.
See page 1511 for disclosure information.
ScienceDirectAccess this article on ScienceDirect
- The Peripheral Arterial Disease Pandemic: No Let-up in SightCanadian Journal of CardiologyVol. 37Issue 10
- PreviewIn a recent systematic review it was estimated that the global prevalence of peripheral artery disease (PAD) was 5.6%, with higher prevalence estimates in high-income countries than in low-income countries.1 Worldwide, a total of 237 million people aged 25 years and older were living with PAD in 2015.1 Patients with PAD are at elevated risk of major adverse limb events and major adverse cardiovascular events.2 Extensive evidence suggests that patients with PAD are undertreated with respect to vasculoprotective medications and lifestyle modification.